ATV: Tau (Denali/Takeda)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameATV: Tau (Denali/Takeda)
Drug Alias NameTau targeting bivalent antibody (Denali Therapeutics/Takeda)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionMicrotubule-associated protein tau modulators
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDenali Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDenali Therapeutics IncTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A